Investigational drug lowers angiotensinogen but shows unclear blood pressure benefits
The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, a protein that turns into the hormone that regulates blood pressure—caused a significant and…